Insider Trading activities of Intersect Ent, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Intersect Ent, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Intersect Ent, Inc. since year 2005. Table 2 shows the detailed insider transactions of Intersect Ent, Inc. since 2005. The reporting company's ticker symbol is XENT. The reporting company's CIK number is 1271214.
The total value of stock buying since 2005 is $186,667.
The total value of stock sales since 2005 is $16,060,737.
The total value of stock option exercises since 2005 is $907,599.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Intersect Ent, Inc. (XENT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 32,833 $951,842 22,833 $154,702
2017-09 0 $0 46,472 $1,397,534 22,833 $154,702
2017-08 0 $0 55,258 $1,665,718 22,833 $154,702
2017-07 0 $0 45,335 $1,282,568 22,835 $154,725
2017-06 0 $0 20,000 $521,980 10,000 $12,000
2017-05 0 $0 40,000 $916,900 10,000 $12,000
2017-04 0 $0 21,250 $342,802 10,000 $12,000
2017-03 0 $0 20,000 $300,460 10,000 $12,000
2017-02 0 $0 20,000 $260,180 20,000 $24,000
2016-10 0 $0 4,003 $66,944 400 $480
2016-09 0 $0 32,664 $517,713 28,664 $20,638
2016-08 0 $0 3,977 $67,609 3,977 $1,908
2016-07 0 $0 5,000 $76,645 5,000 $2,400
2016-06 0 $0 500 $7,191 0 $0
2016-05 8,000 $101,112 0 $0 0 $0
2016-04 0 $0 34,103 $640,531 26,000 $30,240
2016-03 0 $0 27,003 $485,785 12,500 $6,000
2016-02 0 $0 3,603 $67,203 0 $0
2016-01 0 $0 19,706 $370,014 8,000 $9,600
2015-12 0 $0 6,820 $135,411 5,700 $4,104
2015-11 0 $0 6,818 $122,730 0 $0
2015-10 0 $0 6,818 $127,619 0 $0
2015-09 0 $0 16,818 $429,336 4,000 $1,920
2015-08 0 $0 6,818 $194,387 0 $0
2015-07 0 $0 31,318 $938,364 12,000 $5,760
2015-06 0 $0 19,318 $565,998 0 $0
2015-05 0 $0 30,183 $717,709 80 $57
2015-04 0 $0 43,661 $1,134,219 16,000 $13,008
2015-03 0 $0 35,661 $831,580 8,000 $8,000
2015-02 0 $0 35,661 $790,306 5,099 $5,099
2015-01 0 $0 6,300 $133,459 6,300 $6,804
2014-09 5,000 $85,555 0 $0 0 $0
2014-08 0 $0 0 $0 16,250 $100,750

Table 2. Detailed insider stock purchases, sales, and option exercises of Intersect Ent, Inc. insiders (XENT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-16 Earnhardt Lisa D (President and CEO) Sale 20,000 28.37 567,340
2017-10-16 Earnhardt Lisa D (President and CEO) Option Ex 10,000 1.20 12,000
2017-10-04 Hilleman Jeryl L (Chief Financial Officer) Sale 12,833 29.96 384,502
2017-10-04 Hilleman Jeryl L (Chief Financial Officer) Option Ex 12,833 11.12 142,702
2017-09-25 Kaufman Richard E (Sr VP& Chief Operating Officer) Sale 13,639 28.98 395,190
2017-09-15 Earnhardt Lisa D (President and CEO) Sale 20,000 30.19 603,880
2017-09-15 Earnhardt Lisa D (President and CEO) Option Ex 10,000 1.20 12,000
2017-09-05 Hilleman Jeryl L (Chief Financial Officer) Sale 12,833 31.05 398,464
2017-09-05 Hilleman Jeryl L (Chief Financial Officer) Option Ex 12,833 11.12 142,702
2017-08-28 Kaufman Richard E (Sr VP& Chief Operating Officer) Sale 2,425 30.00 72,750
2017-08-25 Kaufman Richard E (Sr VP& Chief Operating Officer) Sale 20,000 30.25 604,940
2017-08-15 Earnhardt Lisa D (President and CEO) Sale 20,000 30.79 615,820
2017-08-15 Earnhardt Lisa D (President and CEO) Option Ex 10,000 1.20 12,000
2017-08-04 Hilleman Jeryl L (Chief Financial Officer) Sale 12,833 29.00 372,208
2017-08-04 Hilleman Jeryl L (Chief Financial Officer) Option Ex 12,833 11.12 142,702
2017-07-25 Kaufman Richard E (Sr VP& Chief Operating Officer) Sale 12,500 28.25 353,112
2017-07-17 Earnhardt Lisa D (President and CEO) Sale 20,000 29.03 580,640
2017-07-17 Earnhardt Lisa D (President and CEO) Option Ex 10,000 1.20 12,000
2017-07-10 Hilleman Jeryl L (Chief Financial Officer) Sale 12,835 27.18 348,816
2017-07-10 Hilleman Jeryl L (Chief Financial Officer) Option Ex 12,835 11.12 142,725
2017-06-15 Earnhardt Lisa D (President and CEO) Sale 20,000 26.10 521,980
2017-06-15 Earnhardt Lisa D (President and CEO) Option Ex 10,000 1.20 12,000
2017-05-22 Kaufman Richard E (Sr VP& Chief Operating Officer) Sale 20,000 22.87 457,380
2017-05-15 Earnhardt Lisa D (President and CEO) Sale 20,000 22.98 459,520
2017-05-15 Earnhardt Lisa D (President and CEO) Option Ex 10,000 1.20 12,000
2017-04-20 Kaufman Richard E (Sr VP& Chief Operating Officer) Sale 1,250 17.25 21,562
2017-04-17 Earnhardt Lisa D (President and CEO) Sale 20,000 16.06 321,240
2017-04-17 Earnhardt Lisa D (President and CEO) Option Ex 10,000 1.20 12,000
2017-03-15 Earnhardt Lisa D (President and CEO) Sale 20,000 15.02 300,460
2017-03-15 Earnhardt Lisa D (President and CEO) Option Ex 10,000 1.20 12,000
2017-02-15 Earnhardt Lisa D (President and CEO) Sale 20,000 13.01 260,180
2017-02-15 Earnhardt Lisa D (President and CEO) Option Ex 20,000 1.20 24,000
2016-10-20 Kaufman Richard E (Sr VP& Chief Operating Officer) Sale 3,603 16.58 59,744
2016-10-17 Earnhardt Lisa D (President and CEO) Sale 400 18.00 7,200
2016-10-17 Earnhardt Lisa D (President and CEO) Option Ex 400 1.20 480
2016-09-07 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Sale 8,664 15.67 135,773
2016-09-07 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Option Ex 8,664 .72 6,238
2016-09-06 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Sale 20,000 15.90 317,940
2016-09-06 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Option Ex 20,000 .72 14,400
2016-09-06 Stambaugh James (VP Clinical Affairs) Sale 3,700 16.00 59,200
2016-09-02 Stambaugh James (VP Clinical Affairs) Sale 300 16.00 4,800
2016-08-03 Stambaugh James (VP Clinical Affairs) Sale 3,977 17.00 67,609
2016-08-03 Stambaugh James (VP Clinical Affairs) Option Ex 3,977 .48 1,908
2016-07-18 Stambaugh James (VP Clinical Affairs) Sale 5,000 15.33 76,645
2016-07-18 Stambaugh James (VP Clinical Affairs) Option Ex 5,000 .48 2,400
2016-06-13 Stambaugh James (VP Clinical Affairs) Sale 500 14.38 7,191
2016-05-16 Gallahue Kieran Buy 8,000 12.64 101,112
2016-04-27 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Sale 2,000 20.01 40,016
2016-04-27 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Option Ex 2,000 .72 1,440
2016-04-20 Kaufman Richard E (Sr VP& Chief Operating Officer) Sale 3,603 18.86 67,934
2016-04-18 Earnhardt Lisa D (President and CEO) Sale 8,500 19.50 165,741
2016-04-18 Earnhardt Lisa D (President and CEO) Option Ex 4,000 1.20 4,800
2016-04-15 Earnhardt Lisa D (President and CEO) Sale 20,000 18.34 366,840
2016-04-15 Earnhardt Lisa D (President and CEO) Option Ex 20,000 1.20 24,000
2016-03-21 Kaufman Richard E (Sr VP& Chief Operating Officer) Sale 3,603 16.51 59,485
2016-03-15 Earnhardt Lisa D (President and CEO) Sale 9,000 18.01 162,081
2016-03-14 Moll Frederic H Sale 1,299 18.53 24,066
2016-03-08 Moll Frederic H Sale 601 18.56 11,153
2016-03-03 Moll Frederic H Sale 12,500 18.32 229,000
2016-03-03 Moll Frederic H Option Ex 12,500 .48 6,000
2016-02-22 Kaufman Richard E (Sr VP& Chief Operating Officer) Sale 3,603 18.65 67,203
2016-01-21 Kaufman Richard E (Sr VP& Chief Operating Officer) Sale 3,603 17.87 64,392
2016-01-20 Kaufman Richard E (Sr VP& Chief Operating Officer) Sale 3,603 17.99 64,810
2016-01-15 Earnhardt Lisa D (President and CEO) Sale 12,500 19.27 240,812
2016-01-15 Earnhardt Lisa D (President and CEO) Option Ex 8,000 1.20 9,600
2015-12-28 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Option Ex 5,700 .72 4,104
2015-12-15 Earnhardt Lisa D (President and CEO) Sale 6,820 19.86 135,411
2015-11-16 Earnhardt Lisa D (President and CEO) Sale 6,818 18.00 122,730
2015-10-15 Earnhardt Lisa D (President and CEO) Sale 6,818 18.72 127,619
2015-09-15 Earnhardt Lisa D (President and CEO) Sale 6,818 25.99 177,227
2015-09-11 Moll Frederic H Sale 10,000 25.21 252,109
2015-09-02 Stambaugh James (VP Clinical Affairs) Option Ex 4,000 .48 1,920
2015-08-17 Earnhardt Lisa D (President and CEO) Sale 6,818 28.51 194,387
2015-07-20 Stambaugh James (VP Clinical Affairs) Sale 12,000 30.52 366,204
2015-07-20 Stambaugh James (VP Clinical Affairs) Option Ex 12,000 .48 5,760
2015-07-15 Earnhardt Lisa D (President and CEO) Sale 19,318 29.62 572,160
2015-06-15 Earnhardt Lisa D (President and CEO) Sale 19,318 29.30 565,998
2015-05-15 Kaufman Richard E (See Remarks) Sale 8,000 23.97 191,768
2015-05-15 Earnhardt Lisa D (President and CEO) Sale 19,318 23.69 457,624
2015-05-11 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Sale 80 23.10 1,848
2015-05-11 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Option Ex 80 .72 57
2015-05-08 Stambaugh James (VP Clinical Affairs) Sale 2,785 23.87 66,469
2015-04-15 Earnhardt Lisa D (See Remarks) Sale 19,318 25.96 501,553
2015-04-13 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Sale 16,000 26.25 419,920
2015-04-13 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Option Ex 16,000 .81 13,008
2015-04-01 Stambaugh James (VP Clinical Affairs) Sale 8,343 25.50 212,746
2015-03-16 Earnhardt Lisa D (See Remarks) Sale 19,318 23.56 455,054
2015-03-11 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Sale 8,000 23.06 184,496
2015-03-11 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Option Ex 8,000 1.00 8,000
2015-03-09 Stambaugh James (VP Clinical Affairs & Reimb.) Sale 8,343 23.02 192,030
2015-02-17 Earnhardt Lisa D (See Remarks) Sale 19,318 22.69 438,344
2015-02-12 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Sale 5,099 22.16 112,993
2015-02-12 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Option Ex 5,099 1.00 5,099
2015-02-11 Wolbeck Amy (V.P. Regulatory Affairs & Qlty) Sale 2,901 22.05 63,967
2015-02-02 Stambaugh James (VP Clinical Affairs & Reimb.) Sale 8,343 20.98 175,002
2015-01-26 Binney Robert H Jr (Vice President, Sales) Sale 6,300 21.18 133,459
2015-01-26 Binney Robert H Jr (Vice President, Sales) Option Ex 6,300 1.08 6,804
2014-09-11 Lucchese Cynthia L (Director) Buy 5,000 17.11 85,555
2014-08-06 Moll Frederic H (Director) Option Ex 16,250 6.20 100,750

Insider trading activities including stock purchases, stock sales, and option exercises of XENT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Intersect Ent, Inc. (symbol XENT, CIK number 1271214) see the Securities and Exchange Commission (SEC) website.